<DOC>
	<DOCNO>NCT02073981</DOCNO>
	<brief_summary>This study implement identify factor impact improvement exacerbation non-motor symptom , provide information contributing development medical care field improvement patient ' QOL , clarify association use istradefylline non-motor symptom QOL .</brief_summary>
	<brief_title>Observational Study Non-motor Symptoms Treatment Parkinson 's Disease Patients</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Patients wear treatment levodopacontaining drug administer least three time daily Patients least one nonmotor symptom complication Patients least 20 year age time consent Patients give write consent Patients receive outpatient care Patients dementia score 23 less MiniMental State Examination ( MMSE ) Patients , opinion investigator subinvestigator , condition impair proper assessment MDSUPDRS PDQ8 ( e.g. , patient receive treatment malignant tumor )</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Parkinson Disease</keyword>
</DOC>